300 related articles for article (PubMed ID: 34747484)
1. The Incidence of Breast Cancer Recurrence 10-32 Years After Primary Diagnosis.
Pedersen RN; Esen BÖ; Mellemkjær L; Christiansen P; Ejlertsen B; Lash TL; Nørgaard M; Cronin-Fenton D
J Natl Cancer Inst; 2022 Mar; 114(3):391-399. PubMed ID: 34747484
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer recurrence in older women five to ten years after diagnosis.
Bosco JL; Lash TL; Prout MN; Buist DS; Geiger AM; Haque R; Wei F; Silliman RA;
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):2979-83. PubMed ID: 19843686
[TBL] [Abstract][Full Text] [Related]
3. Mortality After Late Breast Cancer Recurrence in Denmark.
Pedersen RN; Mellemkjær L; Ejlertsen B; Nørgaard M; Cronin-Fenton DP
J Clin Oncol; 2022 May; 40(13):1450-1463. PubMed ID: 35171656
[TBL] [Abstract][Full Text] [Related]
4. Late recurrence in pediatric cancer: a report from the Childhood Cancer Survivor Study.
Wasilewski-Masker K; Liu Q; Yasui Y; Leisenring W; Meacham LR; Hammond S; Meadows AT; Robison LL; Mertens AC
J Natl Cancer Inst; 2009 Dec; 101(24):1709-20. PubMed ID: 19966206
[TBL] [Abstract][Full Text] [Related]
5. Association of Circulating Tumor Cells With Late Recurrence of Estrogen Receptor-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Sparano J; O'Neill A; Alpaugh K; Wolff AC; Northfelt DW; Dang CT; Sledge GW; Miller KD
JAMA Oncol; 2018 Dec; 4(12):1700-1706. PubMed ID: 30054636
[TBL] [Abstract][Full Text] [Related]
6. Statin use and breast cancer recurrence in postmenopausal women treated with adjuvant aromatase inhibitors: a Danish population-based cohort study.
Harborg S; Heide-Jørgensen U; Ahern TP; Ewertz M; Cronin-Fenton D; Borgquist S
Breast Cancer Res Treat; 2020 Aug; 183(1):153-160. PubMed ID: 32572715
[TBL] [Abstract][Full Text] [Related]
7. Outcomes After Sentinel Lymph Node Biopsy and Radiotherapy in Older Women With Early-Stage, Estrogen Receptor-Positive Breast Cancer.
Carleton N; Zou J; Fang Y; Koscumb SE; Shah OS; Chen F; Beriwal S; Diego EJ; Brufsky AM; Oesterreich S; Shapiro SD; Ferris R; Emens LA; Tseng G; Marroquin OC; Lee AV; McAuliffe PF
JAMA Netw Open; 2021 Apr; 4(4):e216322. PubMed ID: 33856473
[TBL] [Abstract][Full Text] [Related]
8. Association of the Implant Surface Texture Used in Reconstruction With Breast Cancer Recurrence.
Lee KT; Kim S; Jeon BJ; Pyon JK; Mun GH; Ryu JM; Lee SK; Yu J; Kim SW; Lee JE; Nam SJ; Bang SI
JAMA Surg; 2020 Dec; 155(12):1132-1140. PubMed ID: 33026424
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with late recurrence after completion of 5-year adjuvant tamoxifen in estrogen receptor positive breast cancer.
Lee ES; Han W; Kim MK; Kim J; Yoo TK; Lee MH; Lee KH; Kim TY; Moon HG; Im SA; Noh DY; Lee ES
BMC Cancer; 2016 Jul; 16():430. PubMed ID: 27388210
[TBL] [Abstract][Full Text] [Related]
10. Assessment of 25-Year Survival of Women With Estrogen Receptor-Positive/ERBB2-Negative Breast Cancer Treated With and Without Tamoxifen Therapy: A Secondary Analysis of Data From the Stockholm Tamoxifen Randomized Clinical Trial.
Dar H; Johansson A; Nordenskjöld A; Iftimi A; Yau C; Perez-Tenorio G; Benz C; Nordenskjöld B; Stål O; Esserman LJ; Fornander T; Lindström LS
JAMA Netw Open; 2021 Jun; 4(6):e2114904. PubMed ID: 34190995
[TBL] [Abstract][Full Text] [Related]
11. Incident malignancies among older long-term breast cancer survivors and an age-matched and site-matched nonbreast cancer comparison group over 10 years of follow-up.
Clough-Gorr KM; Thwin SS; Bosco JL; Silliman RA; Buist DS; Pawloski PA; Quinn VP; Prout MN
Cancer; 2013 Apr; 119(8):1478-85. PubMed ID: 23280284
[TBL] [Abstract][Full Text] [Related]
12. Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situ.
Curigliano G; Disalvatore D; Esposito A; Pruneri G; Lazzeroni M; Guerrieri-Gonzaga A; Luini A; Orecchia R; Goldhirsch A; Rotmensz N; Bonanni B; Viale G
Ann Oncol; 2015 Apr; 26(4):682-687. PubMed ID: 25600567
[TBL] [Abstract][Full Text] [Related]
13. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
14. Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer. Swedish Breast Cancer Cooperative Group.
J Natl Cancer Inst; 1996 Nov; 88(21):1543-9. PubMed ID: 8901852
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer recurrence after reoperation for surgical bleeding.
Pedersen RN; Bhaskaran K; Heide-Jørgensen U; Nørgaard M; Christiansen PM; Kroman N; Sørensen HT; Cronin-Fenton DP
Br J Surg; 2017 Nov; 104(12):1665-1674. PubMed ID: 28782800
[TBL] [Abstract][Full Text] [Related]
16. Risk of Recurrence or Contralateral Breast Cancer More than 5 Years After Diagnosis of Hormone Receptor-Positive Early-Stage Breast Cancer.
Wilson S; Speers C; Tyldesley S; Chia S; Kennecke H; Ellard S; Lohrisch C
Clin Breast Cancer; 2016 Aug; 16(4):284-90. PubMed ID: 26705158
[TBL] [Abstract][Full Text] [Related]
17. Prediction of late disease recurrence and extended adjuvant letrozole benefit by the HOXB13/IL17BR biomarker.
Sgroi DC; Carney E; Zarrella E; Steffel L; Binns SN; Finkelstein DM; Szymonifka J; Bhan AK; Shepherd LE; Zhang Y; Schnabel CA; Erlander MG; Ingle JN; Porter P; Muss HB; Pritchard KI; Tu D; Rimm DL; Goss PE
J Natl Cancer Inst; 2013 Jul; 105(14):1036-42. PubMed ID: 23812955
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer recurrence, bone metastases, and visceral metastases in women with stage II and III breast cancer in Denmark.
Cronin-Fenton D; Kjærsgaard A; Nørgaard M; Amelio J; Liede A; Hernandez RK; Sørensen HT
Breast Cancer Res Treat; 2018 Jan; 167(2):517-528. PubMed ID: 28948396
[TBL] [Abstract][Full Text] [Related]
19. Effect of standard low-dose anthracycline chemotherapy on late congestive heart failure in breast cancer survivors aged between 50 and 59 at diagnosis: A nationwide study.
Chung IY; Lee JW; Moon HG; Shin KH; Han W; Son BH; Ahn SH; Noh DY
Breast; 2020 Oct; 53():125-129. PubMed ID: 32771950
[TBL] [Abstract][Full Text] [Related]
20. Recurrence dynamics of breast cancer according to baseline body mass index.
Biganzoli E; Desmedt C; Fornili M; de Azambuja E; Cornez N; Ries F; Closon-Dejardin MT; Kerger J; Focan C; Di Leo A; Nogaret JM; Sotiriou C; Piccart M; Demicheli R
Eur J Cancer; 2017 Dec; 87():10-20. PubMed ID: 29096156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
